Article info

Download PDFPDF

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer

Authors

  1. Correspondence to Dr Dong-Wan Kim; kimdw{at}snu.ac.kr
View Full Text

Citation

Blackhall F, Ross Camidge D, Shaw AT, et al
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer

Publication history

  • Received May 18, 2017
  • Accepted May 29, 2017
  • First published August 17, 2017.
Online issue publication 
August 17, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.